Sugi Predict

Sugi Predict / Compounds / SCHEMBL8627052

SCHEMBL8627052

SCHEMBL8627052

CCCCCCC(O)CC(O)CCCCCCCCC(=O)O

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 3/20 0.85
▸ FFAR1 O14842 3/20 0.85
▸ GPR84 Q9NQS5 11/20 0.65
▸ PPARG P37231 7/20 0.65
▸ PPARD Q03181 7/20 0.65
▸ PPARA Q07869 7/20 0.65
▸ HDAC11 Q96DB2 5/20 0.65
▸ TSHR P16473 4/20 0.65
▸ PTPN1 P18031 3/20 0.65
▸ ALDH1A1 P00352 2/20 0.65
▸ TLR2 O60603 2/20 0.65
▸ TDP1 Q9NUW8 2/20 0.65
▸ FABP4 P15090 2/20 0.65
▸ SLC22A6 Q4U2R8 1/20 0.65
▸ SLC22A8 Q8TCC7 1/20 0.65
▸ MEN1 O00255 1/20 0.65
▸ ESR1 P03372 1/20 0.65
▸ ALOX15 P16050 1/20 0.65
▸ PDE4A P27815 1/20 0.65
▸ KMT2A Q03164 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8502359 1.00 FFAR4 (0.85) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL28874225 0.96 FFAR4 (0.86) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL22400861 0.92 FFAR4 (1.00) FFAR4FFAR1GPR84PPARGPPARD
Palmitic Acid SCHEMBL20818808 0.92 FFAR4 (1.00) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL22400867 0.92 FFAR4 (1.00) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL25190974 0.92 FFAR4 (1.00) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL22400864 0.92 FFAR4 (1.00) FFAR4FFAR1GPR84PPARGPPARD
Azelaic Acid SCHEMBL25433337 0.92 FFAR4 (1.00) FFAR4FFAR1GPR84PPARGPPARD
Palmitic Acid SCHEMBL21526666 0.92 FFAR4 (1.00) FFAR4FFAR1GPR84PPARGPPARD
Sebacic Acid SCHEMBL25270035 0.92 FFAR4 (1.00) FFAR4FFAR1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025128741-A1 OCTADECANOID COMPOSITIONS AND METHODS OF ACTIVATING MUCOSAL REPAIR PATHWAYS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-06-19 — — WO claimed
WO-2024063611-A2 LONG-CHAIN FATTY ACID OR DERIVATIVE THEREOF FOR STRONGLY ACTIVATING FATTY ACID RECEPTOR 박진병 2024-03-28 — — WO claimed
CN-115532070-A Reverse osmosis membrane scale inhibitor for sewage treatment and application thereof 山东华特水处理科技有限公司 2022-12-30 — — CN claimed
CN-115282068-A Organogel carrier, method for producing the same, and cosmetic 伊美莱(广州)医疗技术有限公司 2022-11-04 — — CN claimed
CN-114410080-A Composite material for manufacturing degradable disposable lunch box and preparation method thereof 辽宁金科塑胶科技有限公司 2022-04-29 — — CN claimed
US-20210069141-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2021-03-11 — — US claimed
EP-3097910-B1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID UNIV KYOTO (JP) 2020-05-13 — — EP claimed
EP-2913051-B1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID UNIV KYOTO (JP) 2018-09-19 — — EP claimed
US-20170000752-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2017-01-05 — — US claimed
EP-3097910-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID Kyoto University (JP) 2016-11-30 — — EP claimed
US-20150342916-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID NOSTER INC. (JP) 2015-12-03 — — US claimed
CN-104902887-A Metabolism-improving agent comprising rare fatty acid UNIV KYOTO 2015-09-09 — — CN claimed
EP-2913051-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID Kyoto University (JP) 2015-09-02 — — EP claimed
EP-4740753-A1 INTESTINAL REGULATOR Noster Inc. (JP) 2026-05-13 — — EP disclosed
US-12357601-B2 Composition for inhibiting growth of bacterium having menaquinone synthesis pathway through futalosine or futalosine derivative NOSTER INC. (JP) 2025-07-15 — — US disclosed
WO-2025128741-A1 OCTADECANOID COMPOSITIONS AND METHODS OF ACTIVATING MUCOSAL REPAIR PATHWAYS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-06-19 — — WO disclosed
US-5374681-A Phosphate-free detergent BASF AKTIENGESELLSCHAFT (DE) 1994-12-20 — — US disclosed
US-5330675-A Use of polyacetals based on vinyl ethers and dihydroxy compounds in detergents and cleaners and polyacetals BASF AKTIENGESELLSCHAFT (DE) 1994-07-19 — — US disclosed
WO-1994010225-A1 BLOCK COPOLYACETALS, PROCESS FOR PRODUCING THE SAME AND THEIR USE IN WASHING AND CLEANING AGENTS BASF AKTIENGESELLSCHAFT (DE) 1994-05-11 — — WO disclosed
EP-0548639-A2 Polyacetals based on vinylethers and dihydroxy compounds and their use in detergent compositions BASF Aktiengesellschaft (DE) 1993-06-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150342916-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID FADS1, FASN, ELOVL1 FFAR4 40/4885FFAR1 25/4885GPR84 189/4885
US-20210069141-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID ELOVL1, ELOVL5, ELOVL3 FFAR4 14/4885FFAR1 10/4885GPR84 138/4885
US-20170000752-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID ELOVL1, ELOVL5, ELOVL3 FFAR4 14/4885FFAR1 10/4885GPR84 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.